Abstract
For Teens with Opioid Use Disorders, Bupe Better than Detox‐Rehab‐Relapse
Providers Should Use Insurance Mandate in Pennsylvania
DEA Investigates NFL Teams for Painkiller Abuse
Medicaid Expansion Enabled More Recovery Services in Ohio
For Suboxone, Goodbye Reckitt, Hello Spinoff Indivior
Coming up (Source: Alcoholism and Drug Abuse Weekly)

Abstract
For Teens with Opioid Use Disorders, Bupe Better than Detox‐Rehab‐Relapse
Providers Should Use Insurance Mandate in Pennsylvania
DEA Investigates NFL Teams for Painkiller Abuse
Medicaid Expansion Enabled More Recovery Services in Ohio
For Suboxone, Goodbye Reckitt, Hello Spinoff Indivior
Coming up (Source: Alcoholism and Drug Abuse Weekly)

CONCLUSIONS: The use of buprenorphine products to treat opioid dependence has increased significantly in the past 10 years and has shifted to greater use by primary care physicians, indicating a rapidly changing face of opioid maintenance therapy in the United States. (Am J Addict 2014;XX:XX-XX).
PMID: 25409987 [PubMed – as supplied by publisher] (Source: American Journal on Addictions)

Authors: Soyka M
Abstract
Opioid maintenance therapy with methadone or buprenorphine is an established and first-line treatment for opioid dependence. Risk of diversion and toxicity of opioid prescription drugs, including buprenorphine, causes significant concerns. This is particularly the case in the United States, where the number of related emergency visits is increasing, especially in children. A systematic literature research (Medline, Pubmed) was performed to assess the risk associated with buprenorphine. The search, which was not limited to particular publication years, was performed with the key words buprenorphine AND toxicity (114 counts ) AND children (4 counts) and buprenorphine AND mortality AND children (5 counts). In addition, the author obtained information from rel…

Authors: Yokell MA, Zaller ND, Green TC, Rich JD
Abstract
The diversion, misuse, and non-medically supervised use of buprenorphine and buprenorphine/naloxone by opioid users are reviewed. Buprenorphine and buprenorphine/naloxone are used globally as opioid analgesics and in the treatment of opioid dependency. Diversion of buprenorphine and buprenorphine/naloxone represents a complex medical and social issue, and has been widely documented in various geographical regions throughout the world. We first discuss the clinical properties of buprenorphine and its abuse potential. Second, we discuss its diversion and illicit use on an international level, as well as motivations for those activities. Third, we examine the medical risks and benefits of buprenorphine’s non-medically supervise…

Authors: Yokell MA, Zaller ND, Green TC, Rich JD
Abstract
The diversion, misuse, and non-medically supervised use of buprenorphine and buprenorphine/naloxone by opioid users are reviewed. Buprenorphine and buprenorphine/naloxone are used globally as opioid analgesics and in the treatment of opioid dependency. Diversion of buprenorphine and buprenorphine/naloxone represents a complex medical and social issue, and has been widely documented in various geographical regions throughout the world. We first discuss the clinical properties of buprenorphine and its abuse potential. Second, we discuss its diversion and illicit use on an international level, as well as motivations for those activities. Third, we examine the medical risks and benefits of buprenorphine’s non-medically supervise…

Authors: Soyka M
Abstract
Opioid maintenance therapy with methadone or buprenorphine is an established and first-line treatment for opioid dependence. Risk of diversion and toxicity of opioid prescription drugs, including buprenorphine, causes significant concerns. This is particularly the case in the United States, where the number of related emergency visits is increasing, especially in children. A systematic literature research (Medline, Pubmed) was performed to assess the risk associated with buprenorphine. The search, which was not limited to particular publication years, was performed with the key words buprenorphine AND toxicity (114 counts ) AND children (4 counts) and buprenorphine AND mortality AND children (5 counts). In addition, the author obtained information from rel…

Complete Care Medical Center is now offering outpatient detox treatment with several Certified Suboxone Doctors in South Florida. The treatment is highly effective for those suffering from addiction…(PRWeb November 11, 2014)Read the full story at http://www.prweb.com/releases/suboxone-doctors/south-florida/prweb12317157.htm (Source: PRWeb: Medical Pharmaceuticals)

Complete Care Medical Center is now offering outpatient detox treatment with several Certified Suboxone Doctors in South Florida. The treatment is highly effective for those suffering from addiction…(PRWeb November 11, 2014)Read the full story at http://www.prweb.com/releases/suboxone-doctors/south-florida/prweb12317157.htm (Source: PRWeb: Medical Pharmaceuticals)

In conclusion, faldaprevir 240 mg QD can be coadministered with methadone or buprenorphine/naloxone without dose adjustment, although given the relatively narrow therapeutic windows of these agents, monitoring for opiate overdose and withdrawal may still be appropriate Registered at ClinicalTrials.gov registration number: NCT01637922.
PMID: 25385094 [PubMed – as supplied by publisher] (Source: Antimicrobial Agents and Chemotherapy)